ARCHIVES

DeLap: Seven Years In industry Provided View Of Pressures On Drug Developers

This article is from The Cancer Letter archive.

Vol. 22 No. 31 | August 2, 1996

Download PDF Visit The Full Archive

Related Articles

ODAC Recommends Approval of Evista for Breast Cancer Risk Reduction.

July 27, 2007

ONS Membership Still Climbing, Soars over 15,000

June 23, 1989

FDA Caps Advisors’ Holdings To $50,000 In Firms Affected By Committee Meetings.

August 8, 2008

New RFAs on Retinoids & Carotenoids, Tobacco, NMR Research Resistance

July 27, 1984

ASCO Calls On NCI To Double Funding For Cooperative Group Clinical Trials

December 31, 2010

In Brief: George Santos Wins Bristol-Meyers Award; SG Elects William Creasman President; Levin To MDA

April 1, 1988